Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-pioneers-early-lung-cancer-treatment-with-hybrid-operating-room-image-guided-electromagnetic-navigation-bronchoscopy
https://www.med.cuhk.edu.hk/press-releases/cuhk-pioneers-early-lung-cancer-treatment-with-hybrid-operating-room-image-guided-electromagnetic-navigation-bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

 

To better manage small pulmonary lesions, thoracic surgical professors from The Chinese University of Hong Kong (CUHK) were the first in Asia Pacific region to combine the use of Electromagnetic Navigation Bronchoscopy (ENB) with Hybrid Operating Room since 2015 to allow real-time imaging for surgical localisation and for biopsy. The team has published the world’s first research paper on this surgical approach, allowing significant improvement to accuracy, efficiency and safety. As of now, the thoracic team has helped more than 50 patients to biopsy and the removal of small pulmonary lesions by this technique, of whom over 70% were diagnosed with early lung cancer.

 

ENB is effective for biopsy of difficult-to-reach lesion

Lung cancer is the leading cancer killer in Hong Kong. According to Hong Kong Cancer Registry, more than 4,000 people died of this disease in 2015.

 

For pulmonary nodules discovered incidentally by thoracic imaging, such as a chest X-ray or computed tomography (CT), tissue biopsy is needed to further verify if it is a malignant tumour. The method of biopsy depends on the size and position of the lesion.

 

Dr. Rainbow Wing Hung LAU, Clinical Assistant Professor (honorary), Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, CUHK, said, “The conventional methods for biopsy such as the percutaneous approach and surgical operation are invasive and have a high risk of complications. Also, there is a limit to the area of the lung that traditional bronchoscopy can reach. ENB is a novel practice developed in recent years for localisation and for biopsy of pulmonary lesions.”

 

Before performing ENB, doctors conduct a lung CT scan for the patient and input data into the navigation system. The navigation system will then draw a 3D image of the airways structure and plan a route that guides to the target lesion. During the procedure, doctors need to steer the navigation system bronchoscope to locate the lesion, which is similar to a car global positioning system (GPS) unit.

 

Conventional bronchoscopy usually can only reach the more central parts of the lung, but ENB can go further to the periphery or even the most distal aspects with extremely fine and flexible biopsy tools. 

 

Hybrid Operating Room Provides Real-time Imaging for Precise Localisation and Biopsy of Multiple Small Lesions

Dr. Calvin Sze Hang NG, Associate Professor, Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, CUHK explained, “Although ENB can locate difficult-to-reach lung lesions, there is often a navigational error of 4-6mm due to limitations in electromagnetic positioning. Such error becomes highly significant when lung lesions are smaller than 1cm in diameter. The combined navigational ability of ENB and imaging capabilities of the Hybrid Operating Room allow more effective and accurate diagnostic biopsy of small lesions. The automated 360-degree robotic C-arm imaging device in the hybrid room provides a reconstructed DyanCT image. It works as a camera capturing real-time images that can instantly be compared with the ENB navigation route, enabling fine readjustments to the direction or depth of the ENB, and hence increases the accuracy of the procedure.”

 

Conventional ENB performed in the endoscopy suite can locate lesions with a diameter of 10-15mm while those in the Hybrid Operating Room can target multiple lesions, as small as 2-3mm in diameter.

 

  Conventional ENBHybrid Operating Room ENB
Possible error in location4-6mm<1mm
Manageable lesion size
(in diameter)
10-15mmAs small as 2-3mm

 

Novel use of Fluorescent Dye-marker enables precise resection of very small lesions

The new technique is also useful in surgical operations for resection of small peripheral lung nodules. After locating the nodule with ENB, surgeons inject dye-marker adjacent to the lesion to make it visible for surgical resection.

 

Dr. NG added, “The usual dye marker ‘methylene blue’ we have been using is in a blue colour which may look rather similar to discoloured diseased lung tissue. Our team has made use of fluorescent indocyanine green marking together with near-infrared spectroscopy (NIRF) induced images to perform resection more efficiently, especially when using ultra-minimally invasive single-port video-assisted thoracic surgery (SPVATS). This application allows surgeons to locate and remove the lesion with a smaller wound.

 

Dr. NG, who is also a world pioneer in SPVATS, concluded that the new technique enables biopsy and resection of difficult-to-locate or very small lesions by SPVATS. “Such complex and tailored management of multiple pulmonary lesions, some as small as 2mm, are becoming increasingly important in treatment of early detected cancer and for an ageing population. With the increased accuracy and safety enabled by this set of procedures, the amount of lung tissue resected as well as the potential for complications could be minimised.  Patients can benefit from better preserved pulmonary function and speedier recovery.

 

For patients who are unable to undergo surgery, placement of metal fiducial markers via ENB can assist radiotherapy treatment of the tumour. The CUHK thoracic surgical team is now looking to expand the applications of hybrid operating room image-guided ENB into  endoscopic ablation and robotic ENB, with the aim of moving from minimally-invasive to non-invasive surgery for treatment of small lung tumours.

 

The Faculty of Medicine at CUHK combines the use of Electromagnetic Navigation Bronchoscopy (ENB) with Hybrid Operating Room to allow real-time imaging for surgical localisation and for biopsy of micro pulmonary lesions, some as small as 2mm in diameter. (From left) Dr. Calvin Sze Hang NG, Associate Professor, Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, CUHK and Dr. Rainbow Wing Hung LAU, Clinical Assistant Professor (honorary) from the same division

The Faculty of Medicine at CUHK combines the use of Electromagnetic Navigation Bronchoscopy (ENB) with Hybrid Operating Room to allow real-time imaging for surgical localisation and for biopsy of micro pulmonary lesions, some as small as 2mm in diameter. (From left) Dr. Calvin Sze Hang NG, Associate Professor, Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, CUHK and Dr. Rainbow Wing Hung LAU, Clinical Assistant Professor (honorary) from the same division

Dr. Rainbow Wing Hung LAU says the Faculty was the first in Asia Pacific region to combine the use of Electromagnetic Navigation Bronchoscopy (ENB) with Hybrid Operating Room since 2015, to allow real-time imaging for surgical localisation and for biopsy of micro pulmonary lesions.

Dr. Rainbow Wing Hung LAU says the Faculty was the first in Asia Pacific region to combine the use of Electromagnetic Navigation Bronchoscopy (ENB) with Hybrid Operating Room since 2015, to allow real-time imaging for surgical localisation and for biopsy of micro pulmonary lesions.

Dr. Calvin Sze Hang NG says the thoracic surgery team has helped more than 50 patients to biopsy and the removal of small pulmonary lesions by this technique, of whom over 70% were diagnosed with early lung cancer.

Dr. Calvin Sze Hang NG says the thoracic surgery team has helped more than 50 patients to biopsy and the removal of small pulmonary lesions by this technique, of whom over 70% were diagnosed with early lung cancer.

Mr. Au felt discomfort in the chest and sought medical assistance. He initially thought it was linked to the heart but the check-up revealed suspicious small lesions in his lungs. With the new technology, lesions were removed and were proven to be three lung tumours. Due to early discovery, he does not need to undergo chemotherapy or radiotherapy, but only regular check-ups.

Mr. Au felt discomfort in the chest and sought medical assistance. He initially thought it was linked to the heart but the check-up revealed suspicious small lesions in his lungs. With the new technology, lesions were removed and were proven to be three lung tumours. Due to early discovery, he does not need to undergo chemotherapy or radiotherapy, but only regular check-ups.

The actual scene showing the combined use of Electromagnetic Navigation Bronchoscopy (ENB) with Hybrid Operating Room

The actual scene showing the combined use of Electromagnetic Navigation Bronchoscopy (ENB) with Hybrid Operating Room

More Press Releases

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

International collaboration
CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

Surgical advancement
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Introduces High Frequency Oscillations to Determine Resection Margin Increases the Effectiveness of Complex Epilepsy Surgery by around 30%

CUHK Introduces High Frequency Oscillations to Determine Resection Margin Increases the Effectiveness of Complex Epilepsy Surgery by around 30%

Surgical advancement
CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

Surgical advancement
CUHK and HKBU Launch Spermine Risk Score for Prostate Cancer Diagnosis

CUHK and HKBU Launch Spermine Risk Score for Prostate Cancer Diagnosis

Research
CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

Research
CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

Research
CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
Professor Tony Mok Recognised as a Giant of Cancer Care  for His Remarkable Contribution in Advancing Global Healthcare in Lung Cancer

Professor Tony Mok Recognised as a Giant of Cancer Care for His Remarkable Contribution in Advancing Global Healthcare in Lung Cancer

Awards and honors
CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection  Using Flexible Endoscopic Robotic System

CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection Using Flexible Endoscopic Robotic System

Surgical advancement
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

Research
World’s First Large-scale Epidemiological Survey on Adolescents by CUHK Reveals Abuse of Methamphetamine Associated with Increased Risk of Developing Lower Urinary Tract Symptoms

World’s First Large-scale Epidemiological Survey on Adolescents by CUHK Reveals Abuse of Methamphetamine Associated with Increased Risk of Developing Lower Urinary Tract Symptoms

Clinical service
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

Clinical service
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

Research
CUHK-PWH Hybrid Cardiovascular Operating Theatre Officially Opens Multi-functional Setting Enhances Surgical Outcomes

CUHK-PWH Hybrid Cardiovascular Operating Theatre Officially Opens Multi-functional Setting Enhances Surgical Outcomes

Clinical service
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.